World of DTC Marketing

AUGUST 12, 2022

In the past 12 months, PhRMA and closely allied groups spent at least $57 million — $19 million of it since July — on TV , cable , radio , and social media ads opposing price negotiations, according to monitoring by the advocacy group Patients for Affordable Drugs. First, let’s clarify how the bill saves taxpayers billions.

Pharma 255

Pharma Retail Pharmaceutical manufacturing Pharmaceutical 255

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

Pharmaceutical manufacturing 85

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 85

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 80

Patients Pharma Consulting Transportation 80

PM360

JUNE 26, 2023

Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. drug manufacturers to continue producing generic drugs. Over 300 drugs in the U.S.

Manufacturing 97

Manufacturing Pharmaceutical manufacturing Pharma Management 97

Pharmaceutical Technology

SEPTEMBER 13, 2022

The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

pharmaphorum

AUGUST 4, 2022

In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges. If not internally, such specialist training programmes can be outsourced to third-party organisations, whether that involves pharmaceuticals, in vitro diagnostics (IVDs) or QP training. Harness technology.

Recruitment 94

Recruitment Pharma Training Pharmaceutical manufacturing 94

pharmaphorum

NOVEMBER 25, 2022

Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society. Alberto Chiesi deemed Italian pharmaceutical industries the “reference leaders in Europe”. Going beyond the standards of care; improving drug safety and efficacy.

Pharmaceutical 96

Pharmaceutical Manufacturing Medicine Competition 96

European Pharmaceutical Review

NOVEMBER 8, 2022

3) policing anticompetitive settlements between competing drug manufacturers. European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 5) monitoring access to biosimilars. Conclusion.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. At the same time, a “drug lag” persists in China for global pharmaceutical companies’ products. in the U.S.

Marketing 105

Marketing Insurance Medical Manufacturing 105

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5

Prescription 105

Prescription Medical Side effects Patients 105

Medico Reach

FEBRUARY 8, 2023

The pharmaceutical sector has witnessed a steep growth in recent times. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The pharmaceutical industry is no different.

Pharma 52

Pharma Medicine Marketing Prospecting 52

European Pharmaceutical Review

JULY 25, 2022

While the global trade of fake pharmaceuticals has long been a threat, the COVID-19 pandemic sent the fraudulent market into overdrive. ” These products are disguised as legitimate branded medicines and it can be difficult for those across the supply chain, as well as patients, to detect counterfeit products from authentic originals.

Pharmaceutical 83

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 83

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Pharmaceutical Technology

AUGUST 3, 2022

The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development. If clinical trials prove successful, that same process should then be scaled to commercial manufacturing. Key formulation challenges and considerations.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Safety Manufacturing Pharmaceutical 52

PM360

APRIL 25, 2023

pharmaceutical industry. Switching patients from brand to biosimilar, as well as between biosimilars, was also highlighted in the survey. Forty-four percent of gastroenterologists said switching patients was a top concern followed by 40% of dermatologists and 37% of rheumatologists.

Marketing 97

Marketing Competition Government Manufacturing 97

Pharmaceutical Technology

MAY 11, 2008

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. The pilot scheme for this has been observed by the FDA and EU Commission.

Electronics 52

Electronics Transportation Pharmaceutical manufacturing Pharmaceutical 52